Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
3038 Views
Dr KK Aggarwal 17 May 2021
The mRNA vaccines are highly effective in protecting against symptomatic COVID-19 among the healthcare personnel (HCPs), according to interim results from the largest COVID-19 vaccine effectiveness study conducted by the CDC. Among fully vaccinated HCPs, the two FDA-approved mRNA vaccines - Pfizer-BioNTech and Moderna - reduced the risk of becoming sick with COVID-19 by 94%.
Data for this assessment come from a network covering 500,000 HCP across 33 sites in 25 states in the US, providing additional robust evidence that mRNA vaccines are effective against symptomatic illness in real-world conditions.
In this study, the vaccination status of COVID-19 positive cases (n=623) was compared with the vaccination status of those who tested negative, who served as controls (n=1220). Comparison of the odds of COVID-19 vaccination in cases and controls was used to calculate the vaccine effectiveness estimates.
The fully vaccinated (≥7days after receipt of a second vaccine dose) HCP had 94% less likelihood of developing symptomatic illness, whereas the partially vaccinated (≥14 days after receipt of dose one through six days after dose two) were 82% less likely to develop symptoms.
These observations support the recommendation that both doses (complete vaccination) are necessary to get maximum protection.
(Source: CDC Press Release, May 14, 2021)
Dr KK Aggarwal
President CMAAO, HCFI and Past National President IMA
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}